Adcytherix Launches with €30 Million Seed Funding to Pioneer Next-Generation Antibody-Drug Conjugates for Cancer Treatment

Vision is to establish a leading ADC developer to treat high unmet need diseases such as cancer. Founded by the team that founded and sold Emergence T...

June 11, 2024 | Tuesday | News
NMD Pharma Initiates Phase 2b Trial of NMD670 in Generalized Myasthenia Gravis Patients

NMD Pharma A/S, a clinical-stage biotech company dedicated to developing novel and improved treatments for patients living with neuromuscular diseases, a...

June 11, 2024 | Tuesday | News
Essential Pharma Partners with AGC Biologics for Late-Phase Manufacturing of Promising Neuroblastoma Immunotherapy

Essential Pharma reaches agreement with AGC Biologics for late phase clinical manufacturing of its immunotherapy candidate for the treatment of high-risk...

June 11, 2024 | Tuesday | News
Danish MedTech Company °MEQU Secures FDA Clearance for Portable Blood and IV Fluid Warmer

Danish MedTech company, °MEQU announces 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) of the °M Warmer System - a ...

June 10, 2024 | Monday | News
FDA Grants Emergency Use Authorization for Roche's Rapid PCR Test for SARS-CoV-2, Influenza A/B, and RSV

The test uses highly sensitive PCR technology, requiring only a single nasal-swab sample to provide rapid, accurate qualitative detection and different...

June 10, 2024 | Monday | News
Vetter Announces Expansion Plans to Boost Capacity in the U.S. and Germany

  Vetter Advisory Board decides on strategic path forward for further independent and sustainable growth    Des Plaines, IL, and Saa...

June 07, 2024 | Friday | News
Thermo Fisher Scientific Enhances Chromosomal Microarray Analysis Solutions to Align with IVDR Regulation

   These enhancements represent Thermo Fisher's steadfast commitment to ensuring the highest standards of safety and efficacy in cytogenetic t...

May 31, 2024 | Friday | News
EU Committee Recommends Dupixent as Breakthrough Therapy for Uncontrolled COPD with Raised Blood Eosinophilsv

Recommendation for adults with uncontrolled COPD with raised blood eosinophils based on data from two landmark Phase 3 trials demonstrating Dupixent sign...

May 31, 2024 | Friday | News
Avance Clinical and Julius Clinical Forge Global Partnership to Accelerate Biotech Trials

Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs has signed a Memorandum of Understanding (MOU) with Juli...

May 31, 2024 | Friday | News
AstraZeneca's TROPION-Lung01 Trial Reveals Datopotamab Delxtecan's Potential as New Treatment Option for Advanced Lung Cancer

TROPION-Lung01 Phase III trial had a local progressive or metastatic non-small cell lung cancer with at least one treatment history in the past ( Datopot...

May 29, 2024 | Wednesday | News
Stryker Introduces Gamma4 Hip Fracture Nailing System in Europe, Transforming Surgical Treatment

Stryker a global leader in medical technologies, announced that the first surgeries using the Gamma4 Hip Fracture Nailing System in Europe were completed...

May 29, 2024 | Wednesday | News
EU-Funded Project by Bio-Sourcing, Ciloa, and Intract Pharma Targets Inflammatory Diseases

  AB-BIOBETTER, led by Bio-Sourcing, to pioneer development of new oral formulation of adalimumab for inflammatory bowel diseases; offering patient...

May 28, 2024 | Tuesday | News
Helsinn Group and Angelini Pharma Renew Distribution Agreement for AULIN® and MESULID® in Eastern Europe

Helsinn Group (“Helsinn”), a global pharmaceutical company with a track record of over forty-five years of commercial execution and a strong ...

May 28, 2024 | Tuesday | News
HealthTech Bioactives Partners with Abolis Biotechnologies to Revolutionize Polyphenol Production

HealthTech Bioactives (HTBA) the leading innovator in polyphenol and vitamin B12 solutions for human and animal health and nutrition, is pleased to annou...

May 27, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close